UnicoCell Biomed Co., Ltd.

Company Profile

Sector

Healthcare

Industry

Biotechnology

Employees

N/A

Website

www.unicocell.com

Country

Taiwan

Exchange

Taiwan

Founded 2011

UnicoCell Biomed provides the research and development of stem cell drugs in Taiwan and Japan. The company develops ELIXCYTE for the treatment of knee osteoarthritis and chronic kidney disease.

It also operates an allogeneic adipose stem cell bank, as well as autologous stem cell therapy. Its portfolio also includes conditioned medium, UnicoVial, a cryogenic vial for the storage of cell products and biological samples under ultra-low temperature, and laboratory testing services, which include sterility, endotoxin, mycoplasma, and cell count and viability tests Contract development and manufacturing organization (CDMO) services for cell-based products. Founded in 2011, UnicoCell Biomed is based in Taipei, Taiwan.

Key Stats

52-Week Range

NT$62.90NT$96.00

Beta-0.23

Trailing P/EN/A

Forward P/EN/A

Trailing EPS-1.77

Avg Volume

Earnings & Analyst

Next EarningsN/A

EPS EstimateN/A

Target Mean PriceN/A

RecommendationNone

Recommendation MeanN/A

Recent SEC Filings

SEC filings for this ticker are not available yet.